NBC Securities’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$536K Buy
2,826
+1,138
+67% +$214K 0.04% 503
2026
Q1
$333K Buy
1,688
+294
+21% +$56.7K 0.03% 662
2025
Q4
$256K Sell
1,394
-59
-4% -$10.3K 0.02% 750
2025
Q3
$223K Buy
1,453
+61
+4% +$9.23K 0.02% 791
2025
Q2
$194K Sell
1,392
-529
-28% -$74.1K 0.02% 843
2025
Q1
$282K Buy
1,921
+1,919
+95,950% +$278K 0.02% 651
2024
Q4
$278 Sell
2
-2,110
-100% -$295K 0.03% 639
2024
Q3
$329K Sell
2,112
-10
-0.5% -$1.61K 0.03% 612
2024
Q2
$331K Sell
2,122
-1
-0% -$150 0.03% 581
2024
Q1
$287K Sell
2,123
-157
-7% -$20.8K 0.03% 617
2023
Q4
$307K Sell
2,280
-11
-0.5% -$1.43K 0.03% 576
2023
Q3
$310K Buy
+2,291
New +$313K 0.03% 533

Other funds holding AZN

NBC Securities's AZN Position: Q2 2026 in Review

NBC Securities increased its AstraZeneca (AZN) stake by 67% in Q2 2026, buying an estimated $214K and bringing the position to 2,826 shares worth $536K. The position accounts for 0.04% of the portfolio, ranked #503.

NBC Securities first reported a position in AZN in Q3 2023 and has held it in 12 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • NBC Securities held 2,826 shares of AstraZeneca worth $536K as of Q2 2026.
  • NBC Securities bought 1,138 AstraZeneca shares in Q2 2026, an estimated $214K.
  • AstraZeneca made up 0.04% of NBC Securities's portfolio in Q2 2026, its #503 holding.
  • NBC Securities first reported a position in AstraZeneca in Q3 2023 and has held it in 12 quarters since.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.